Cargando…

Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved

Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator...

Descripción completa

Detalles Bibliográficos
Autores principales: Karaliūtė, Rasa, Leleika, Arnoldas, Apanavičiūtė, Ieva, Kazakevičius, Tomas, Mizarienė, Vaida, Zabiela, Vytautas, Kavoliūnienė, Aušra, Ragaišytė, Nijolė, Urbonienė, Daiva, Šakalytė, Gintarė
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416115/
https://www.ncbi.nlm.nih.gov/pubmed/36013520
http://dx.doi.org/10.3390/medicina58081053
_version_ 1784776400823123968
author Karaliūtė, Rasa
Leleika, Arnoldas
Apanavičiūtė, Ieva
Kazakevičius, Tomas
Mizarienė, Vaida
Zabiela, Vytautas
Kavoliūnienė, Aušra
Ragaišytė, Nijolė
Urbonienė, Daiva
Šakalytė, Gintarė
author_facet Karaliūtė, Rasa
Leleika, Arnoldas
Apanavičiūtė, Ieva
Kazakevičius, Tomas
Mizarienė, Vaida
Zabiela, Vytautas
Kavoliūnienė, Aušra
Ragaišytė, Nijolė
Urbonienė, Daiva
Šakalytė, Gintarė
author_sort Karaliūtė, Rasa
collection PubMed
description Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator reflecting fibrosis, is associated with laboratory indicators affecting the development of fibrosis, interleukin 6 (IL-6) or tumor necrosis factor α (TNF-α). Materials and Methods: The study included 92 persistent AF patients who underwent elective ECV. The effective maintenance of SR was evaluated after 40 ± 10 days of ECV. Echocardiography, inflammatory markers (high-sensitivity c-reactive protein (hs-CRP), IL-6, and TNF-α), and natriuretic peptides (N-terminal pro b-type natriuretic peptide (NT-proBNP) and N-terminal pro a-type natriuretic peptide (NT-proANP)) were assessed. Results: After a 40 ± 10 days observation period, 51 patients (55.4%) were in SR. Patients with AF recurrence had a significantly longer duration of AF (p = 0.008) and of arterial hypertension (p = 0.035), lower LA ejection fraction (p = 0.009), lower LA strain (p < 0.0001), higher left ventricular global longitudinal strain (p = 0.001), and a higher E/e‘ ratio (p < 0.0001). LA strain was an independent predictor of early AF recurrence (OR: 0.65; 95% Cl 0.5–0.9, p = 0.004). LA strain < 11.85% predicted AF recurrence with 70% sensitivity and 88% specificity (AUC 0.855, 95% CI 0.77–0.94, p < 0.0001). LA strain demonstrated the association with NT-proBNP (r = −0.489, p < 0.0001) and NT-proANP (r = −0.378, p = 0.002), as well as with hs-CRP (r = −0.243, p = 0.04). Conclusions: LA strain appeared to be the most accurate predictor of early AF recurrence after ECV in patients with persistent AF. LA strain inversely correlated with NT-proBNP and NT-proANP, but no significant association with any of the inflammatory markers was identified.
format Online
Article
Text
id pubmed-9416115
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94161152022-08-27 Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved Karaliūtė, Rasa Leleika, Arnoldas Apanavičiūtė, Ieva Kazakevičius, Tomas Mizarienė, Vaida Zabiela, Vytautas Kavoliūnienė, Aušra Ragaišytė, Nijolė Urbonienė, Daiva Šakalytė, Gintarė Medicina (Kaunas) Article Background and objectives: To identify clinical, echocardiographic, and laboratory parameters that affect the early recurrence of atrial fibrillation (AF) after restoring sinus rhythm (SR) by electrical cardioversion (ECV), and to determine whether left atrial (LA) strain, as a noninvasive indicator reflecting fibrosis, is associated with laboratory indicators affecting the development of fibrosis, interleukin 6 (IL-6) or tumor necrosis factor α (TNF-α). Materials and Methods: The study included 92 persistent AF patients who underwent elective ECV. The effective maintenance of SR was evaluated after 40 ± 10 days of ECV. Echocardiography, inflammatory markers (high-sensitivity c-reactive protein (hs-CRP), IL-6, and TNF-α), and natriuretic peptides (N-terminal pro b-type natriuretic peptide (NT-proBNP) and N-terminal pro a-type natriuretic peptide (NT-proANP)) were assessed. Results: After a 40 ± 10 days observation period, 51 patients (55.4%) were in SR. Patients with AF recurrence had a significantly longer duration of AF (p = 0.008) and of arterial hypertension (p = 0.035), lower LA ejection fraction (p = 0.009), lower LA strain (p < 0.0001), higher left ventricular global longitudinal strain (p = 0.001), and a higher E/e‘ ratio (p < 0.0001). LA strain was an independent predictor of early AF recurrence (OR: 0.65; 95% Cl 0.5–0.9, p = 0.004). LA strain < 11.85% predicted AF recurrence with 70% sensitivity and 88% specificity (AUC 0.855, 95% CI 0.77–0.94, p < 0.0001). LA strain demonstrated the association with NT-proBNP (r = −0.489, p < 0.0001) and NT-proANP (r = −0.378, p = 0.002), as well as with hs-CRP (r = −0.243, p = 0.04). Conclusions: LA strain appeared to be the most accurate predictor of early AF recurrence after ECV in patients with persistent AF. LA strain inversely correlated with NT-proBNP and NT-proANP, but no significant association with any of the inflammatory markers was identified. MDPI 2022-08-04 /pmc/articles/PMC9416115/ /pubmed/36013520 http://dx.doi.org/10.3390/medicina58081053 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Karaliūtė, Rasa
Leleika, Arnoldas
Apanavičiūtė, Ieva
Kazakevičius, Tomas
Mizarienė, Vaida
Zabiela, Vytautas
Kavoliūnienė, Aušra
Ragaišytė, Nijolė
Urbonienė, Daiva
Šakalytė, Gintarė
Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
title Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
title_full Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
title_fullStr Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
title_full_unstemmed Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
title_short Risk Factors of Early Atrial Fibrillation Recurrence Following Electrical Cardioversion When Left Ventricular Ejection Fraction Is Preserved
title_sort risk factors of early atrial fibrillation recurrence following electrical cardioversion when left ventricular ejection fraction is preserved
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416115/
https://www.ncbi.nlm.nih.gov/pubmed/36013520
http://dx.doi.org/10.3390/medicina58081053
work_keys_str_mv AT karaliuterasa riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT leleikaarnoldas riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT apanaviciuteieva riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT kazakeviciustomas riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT mizarienevaida riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT zabielavytautas riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT kavoliunieneausra riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT ragaisytenijole riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT urbonienedaiva riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved
AT sakalytegintare riskfactorsofearlyatrialfibrillationrecurrencefollowingelectricalcardioversionwhenleftventricularejectionfractionispreserved